Thyrocare Technologies Limited: September ’21 Results Update
Moneylife Digital Team 19 November 2021
Thyrocare Technologies Limited (Thyrocare) came out with a good set of numbers for Q2FY21-22, helped by one-time government contracts related to COVID tests where government also bore the cost of consumables, thus, adding to top- as well as bottom-line. This enabled the company to achieve highest-ever sales, EBITDA (earnings before interest, taxes, depreciation and amortisation) and EBITDA...
Archived Premium Content
This article is outside your subscription period. You can buy this article individually.
Rs 50-Rs 100 + GST
Access will be given ONLY to this article.
Already a subscriber ? Log in
Free Helpline
Legal Credit